Codes / ICD10CM / M1A.38X1

M1A.38X1 Chronic gout due to renal impairment, vertebrae, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Chronic Gout Due to Renal Impairment, Vertebrae, with Tophus (Tophi)

Summary

Chronic gout due to renal impairment, vertebrae, with tophus is a form of arthritis resulting from prolonged elevated uric acid levels caused by impaired kidney function, specifically affecting the vertebrae (spinal bones). It is characterized by recurrent joint inflammation, tissue damage, and the presence of tophi (urate crystal deposits) in the affected spinal area.

Causes

This condition arises from the kidneys' reduced ability to excrete uric acid, leading to its accumulation in the blood. Over time, urate crystals deposit in the vertebrae and surrounding tissues, triggering inflammation. The underlying renal impairment may stem from chronic kidney disease, kidney failure, or other conditions affecting renal function.

Risk Factors

  • Chronic kidney disease or renal impairment
  • Advanced age
  • Hypertension
  • Diabetes
  • Use of medications that affect renal function (e.g., certain diuretics)
  • Family history of gout or renal disease

Symptoms

  • Recurrent episodes of intense joint pain in the vertebrae
  • Persistent swelling, redness, and warmth in the affected spinal area
  • Formation of tophi (hard, painless lumps) under the skin near the vertebrae
  • Stiffness and limited spinal mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while imaging (e.g., X-rays or MRI) may reveal tophi or joint damage. Joint fluid analysis can confirm urate crystal presence. The underlying renal impairment is assessed through kidney function tests.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., colchicine or NSAIDs). In severe cases, corticosteroids or biologics may be used. Lifestyle modifications, such as dietary changes and hydration, support management.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and tophi may shrink. However, untreated or poorly managed cases can lead to chronic pain and spinal damage. Regular follow-up with a healthcare provider is essential to monitor kidney function and adjust treatment as needed.

Complications

  • Chronic spinal pain and stiffness
  • Progressive spinal joint damage
  • Increased risk of kidney stones or further renal impairment
  • Nerve compression from tophi or joint deformity

Lifestyle & Prevention

  • Limit purine-rich foods (e.g., red meat, seafood)
  • Maintain a healthy weight
  • Stay hydrated to support kidney function
  • Avoid alcohol, which can raise uric acid levels
  • Follow prescribed medication regimens consistently

When to Seek Professional Help

Seek medical attention if you experience severe spinal pain, swelling, or signs of infection (e.g., fever, redness). Prompt care is important if symptoms worsen or new tophi appear, as early intervention can prevent complications.

Tips for Medical Coders

Document the presence of tophi and the specific spinal involvement (vertebrae) to support the code M1A.38X1. Ensure renal impairment is clearly linked to the gout diagnosis, as this is a key clinical criterion. Include details on flare-ups, treatment responses, and any imaging or lab results confirming tophi or joint damage.

Book a walkthrough

M1A.38X1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.